Investor's Business Daily on MSN15h
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain
Tariff uncertainty has cast a pall over medical stocks. Re-shoring is possible, but expensive, leaving them in a "wait-and-see" pattern.
Journey Medical Corporation (DERM) Tops Q4 Earnings Estimates
Journey Medical (DERM) delivered earnings and revenue surprises of 136.36% and 1.84%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Vivani Medical Gives Data for Weight Loss Implant
By Karen Roman Vivani Medical, Inc. (Nasdaq: VANI) announced positive data for NPM-139, its subdermal semaglutide implant for ...